Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Sep 13, 2025

Robotic Taj Mahal Hepatectomy for Hilar Cholangiocarcinoma
09:19

Robotic Taj Mahal Hepatectomy for Hilar Cholangiocarcinoma

Published on: July 14, 2022

3.6K

Robotic Central Hepatectomy.

Emrullah Birgin1, Nuh N Rahbari2

  • 1Department of General and Visceral Surgery, Ulm University Hospital, Ulm, Germany. emrullah.birgin@uniklinik-ulm.de.

Annals of Surgical Oncology
|July 27, 2025
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Beyond non-anatomical resections: Is minimally invasive parenchyma-sparing anatomical hepatectomy the next chapter?

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2026
Same author

Learning Curves and Complexity Evolution in Robotic Liver Surgery: An International Multicenter Study with Comparison to Global Benchmark Outcomes.

Annals of surgery·2026
Same author

Risk factors for posthepatectomy liver failure: a secondary analysis of prospective clinical trials.

Langenbeck's archives of surgery·2026
Same author

Semi-automated isolation of parenchymal and non-parenchymal liver cells from mice and humans with enhanced stellate cell fraction.

Cell & bioscience·2026
Same author

ASO Author Reflections: It Takes Two to SAMBA-Toward Standardized Robotic Parenchymal Transection with Sealing Devices.

Annals of surgical oncology·2026
Same author

Sealer and Moisture-Based Approach (SAMBA) Hepatectomy Technique for Robotic Parenchymal Transection.

Annals of surgical oncology·2026
Same journal

Oncologic Safety of Preoperative Controlled Ovarian Stimulation for Fertility Preservation Among Women with Estrogen Receptor Positive Breast Cancer.

Annals of surgical oncology·2026
Same journal

The Practices of Pancreatic Neck Margin Testing and Their Outcomes after Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma.

Annals of surgical oncology·2026
Same journal

ASO Visual Abstract: Two-Year Outcomes After Direct-to-Surgery in Good Prognosis Margin-Clear Stage II or III Rectal Cancer-The QuickSilver Study.

Annals of surgical oncology·2026
Same journal

ASO Visual Abstract: Is Mastectomy Necessary in Patients with Occult Breast Cancer and Advanced (N2/N3) Nodal Disease?

Annals of surgical oncology·2026
Same journal

ASO Visual Abstract: The Effect of Neoadjuvant Therapy on Post-Recurrence Overall Survival After Curative Resection for Intrahepatic Cholangiocarcinoma.

Annals of surgical oncology·2026
Same journal

Robotic Remnant Total Pancreatectomy After Robotic Pancreaticoduodenectomy (with video).

Annals of surgical oncology·2026
See all related articles

This study demonstrates that robotic central hepatectomy is a safe and effective minimally invasive surgical option for treating giant liver tumors, specifically in cases of metastatic breast cancer.

Area of Science:

  • Hepatobiliary Surgery
  • Surgical Oncology
  • Minimally Invasive Surgery

Background:

  • Central hepatectomies for giant liver tumors are complex surgical procedures.
  • Minimally invasive robotic approaches for centrally located liver tumors are rarely documented.
  • Metastatic breast cancer to the liver presents unique surgical challenges.

Purpose of the Study:

  • To report a case of pure robotic central hepatectomy for metastatic breast cancer.
  • To evaluate the feasibility and safety of robotic surgery for complex liver resections.
  • To assess the outcomes of robotic central hepatectomy in a patient with isolated liver metastasis.

Main Methods:

  • A 69-year-old female patient with metastatic breast cancer underwent a pure robotic central hepatectomy.
Keywords:
AnatomicGlissoneanLiver resectionMesohepatectomyMinimally invasive hepatectomyRobotic parenchymal transectionSectionectomy

More Related Videos

Robotic Left Hepatectomy using Indocyanine Green Fluorescence Imaging for an Intrahepatic Complex Biliary Cyst
11:03

Robotic Left Hepatectomy using Indocyanine Green Fluorescence Imaging for an Intrahepatic Complex Biliary Cyst

Published on: June 24, 2022

5.8K
Robotic Central Pancreatectomy with Roux-en-Y Pancreaticojejunostomy
10:34

Robotic Central Pancreatectomy with Roux-en-Y Pancreaticojejunostomy

Published on: November 20, 2021

5.6K

Related Experiment Videos

Last Updated: Sep 13, 2025

Robotic Taj Mahal Hepatectomy for Hilar Cholangiocarcinoma
09:19

Robotic Taj Mahal Hepatectomy for Hilar Cholangiocarcinoma

Published on: July 14, 2022

3.6K
Robotic Left Hepatectomy using Indocyanine Green Fluorescence Imaging for an Intrahepatic Complex Biliary Cyst
11:03

Robotic Left Hepatectomy using Indocyanine Green Fluorescence Imaging for an Intrahepatic Complex Biliary Cyst

Published on: June 24, 2022

5.8K
Robotic Central Pancreatectomy with Roux-en-Y Pancreaticojejunostomy
10:34

Robotic Central Pancreatectomy with Roux-en-Y Pancreaticojejunostomy

Published on: November 20, 2021

5.6K
  • Resection involved anatomical removal of liver segments 4, 5, and 8 using the Da Vinci Xi system.
  • Procedures included an extrahepatic Glissonean pedicle approach and robotic staplers for vessel and vein transection.

    • Main Results:

    • The robotic central hepatectomy was successfully performed without complications.
    • The patient experienced an uneventful postoperative course and was discharged on postoperative day 6.
    • At 6-month follow-up, the patient maintained normal liver function and showed no signs of disease recurrence.

    Conclusions:

    • Robotic central hepatectomy is a feasible and safe surgical treatment for metastatic breast cancer.
    • Minimally invasive robotic surgery offers a viable alternative for complex liver resections.
    • This approach may improve outcomes for patients with isolated liver metastases.